NRC stock hits 52-week low at $16.44 amid market challenges

Published 28/01/2025, 17:02
NRC stock hits 52-week low at $16.44 amid market challenges

National Research Corporation (NRC) stock has reached a new 52-week low, touching down at $16.44. According to InvestingPro data, the company maintains a GOOD financial health score and demonstrates strong profitability with a 61% gross margin and 21.5% return on assets. This latest price level reflects a significant downturn for the company, which has seen its stock value decrease by 57.61% over the past year. Investors are closely monitoring NRC as it navigates through a challenging period, with market analysts scrutinizing the factors that have led to this decline. The 52-week low serves as a critical indicator of the company’s recent performance and is a focal point for discussions on its future prospects in the competitive landscape. Notably, InvestingPro analysis suggests the stock is currently undervalued, with management actively buying back shares - one of several key insights available in the comprehensive Pro Research Report covering this company.

In other recent news, National Research Corporation, a prominent player in commercial physical and biological research, has announced the impending retirement of its Secretary, Principal Financial (NASDAQ:PFG) Officer, and Principal Accounting Officer, Linda Stacy. After more than 18 years of service, Stacy is set to retire at the end of 2024, marking the end of a significant era for the corporation. The company’s Board of Directors has expressed their gratitude for Stacy’s considerable contributions to the firm’s growth and success.

The company has yet to announce a successor for Stacy’s position. This shift comes as the company continues to navigate the competitive landscape of the research industry. Stacy’s role has been pivotal in overseeing the financial and accounting operations within the company. These recent developments underscore the ongoing changes within National Research Corporation as it continues to focus on enhancing its research services and expanding its market reach.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.